Suppr超能文献

评估SAME-TT2R2评分及其他影响非瓣膜性心房颤动抗凝治疗质量的临床因素:西班牙一项全国性研究

Evaluation of SAMe-TT2R2 score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in Spain.

作者信息

Lobos-Bejarano José M, Barrios Vivencio, Polo-García José, Escobar Carlos, Vargas-Ortega Diego, Marín-Montañés Nuria, Prieto-Valiente Luis, Fuentes Sonia, Prieto Miguel Angel, García-Ortiz Luis

机构信息

a Jazmin Primary Care Health Center, East Area Primary Care , Madrid , Spain ;

b Cardiology Department , University Hospital Ramon y Cajal , Madrid , Spain ;

出版信息

Curr Med Res Opin. 2016 Jul;32(7):1201-7. doi: 10.1185/03007995.2016.1164676. Epub 2016 Apr 7.

Abstract

OBJECTIVE

To assess the major clinical factors affecting the quality of anticoagulation and evaluate the predictive value of the SAMe-TT2R2 score to identify patients who will achieve a high average time in therapeutic range (T.T.R.) with vitamin K antagonist (V.K.A.) treatment.

RESEARCH DESIGN AND METHODS

This observational, cross-sectional, retrospective and nationwide multicenter study included 1524 patients from the primary care setting with non-valvular atrial fibrillation receiving V.K.A. (≥12 months). We performed a bivariate analysis to identify factors individually associated with the T.T.R. and a multiple regression analysis to identify the independent predictive factors. For the validation of the SAMe-TT2R2 score, the receiver operating characteristic (R.O.C.) curve was calculated and the Hosmer-Lemeshow test was used to test calibration.

RESULTS

A total of 94.8% of patients received acenocumarol (4.8% warfarin). A progressive decrease in mean T.T.R. was found when the SAMe-TT2R2 score increased from 0 points (72.1 ± 17.1%) to 4 points (64.1 ± 23.2%), p < 0.001. Other risk scores (CHADS2 and CHA2DS2-VASc, HAS-BLED) were also associated with the mean T.T.R. We found a significant association between low T.T.R. and the following clinical factors: female sex, three or more comorbidities, amiodarone treatment, dietary habits, bleeding history and the intake of ≥7 tablets per day besides V.K.A. (p < 0.01). Regarding SAMe-TT2R2 score validation, the R.O.C. curve showed significant capability, although not high, of discriminating good anticoagulation control (T.T.R. ≥65%) with an area under the curve of 0.562 (95% C.I. 0.533-0.592, p < 0.001) which increased, remaining modest, to 0.594 (95% C.I. 0.564-0.624, p < 0.001) when the factors not included in SAMe-TT2R2 score were added.

CONCLUSION

In this cohort, the SAMe-TT2R2 score had a significant, although modest, ability to assess the likelihood of good international normalized ration (I.N.R.) control, and its predictive value might slightly improve by adding other simple clinical factors. Further research is needed to refine the predictive scales.

摘要

目的

评估影响抗凝质量的主要临床因素,并评估SAMe-TT2R2评分对识别接受维生素K拮抗剂(VKA)治疗后平均治疗范围内时间(TTR)较高患者的预测价值。

研究设计与方法

这项观察性、横断面、回顾性全国多中心研究纳入了1524例来自基层医疗单位、接受VKA治疗(≥12个月)的非瓣膜性心房颤动患者。我们进行了双变量分析以识别与TTR单独相关的因素,并进行多元回归分析以识别独立预测因素。为验证SAMe-TT2R2评分,计算了受试者工作特征(ROC)曲线,并使用Hosmer-Lemeshow检验进行校准检验。

结果

共有94.8%的患者接受醋硝香豆素治疗(4.8%接受华法林治疗)。当SAMe-TT2R2评分从0分(72.1±17.1%)增加到4分(64.1±23.2%)时,平均TTR呈逐渐下降趋势,p<0.001。其他风险评分(CHADS2和CHA2DS2-VASc、HAS-BLED)也与平均TTR相关。我们发现低TTR与以下临床因素之间存在显著关联:女性、三种或更多合并症、胺碘酮治疗、饮食习惯、出血史以及除VKA外每天服用≥7片药物(p<0.01)。关于SAMe-TT2R2评分验证,ROC曲线显示有显著但不高的区分良好抗凝控制(TTR≥65%)的能力,曲线下面积为0.562(95%CI 0.533-0.592,p<0.001),当加入SAMe-TT2R2评分未包含的因素时,曲线下面积增加至0.594(95%CI 0.564-0.624,p<0.001),但仍处于中等水平。

结论

在该队列中,SAMe-TT2R2评分虽有显著但中等的评估国际标准化比值(INR)良好控制可能性的能力,并且通过加入其他简单临床因素其预测价值可能略有提高。需要进一步研究以完善预测量表。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验